Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gallagher

Showing results (131-140 of 189) with videos related to

Pageof 19
Sort By:
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 5, 2014
The relationship between hypophosphataemia and outcomes during low-intensity and high-intensity continuous renal replacement therapyRinaldo Bellomo, Alan Cass, Louise Cole, et al.
Nephrology (Carlton, Vic.)|February 14, 2007
Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: a multicentre, open-label, Australian studyAlex Disney, Peter D E Jersey, Geoff Kirkland, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
The Plasma-Lyte 148 versus Saline (PLUS) statistical analysis plan: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortalityLaurent Billot, Rinaldo Bellomo, Martin Gallagher, et al.
Nephrology (Carlton, Vic.)|June 6, 2020
No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trialBrendan Smyth, Li Zuo, Nicholas A Gray, et al.
Frontiers in Immunology|June 3, 2024
The predictive value of systemic immune-inflammation index for vascular access survival in chronic hemodialysis patientsSong Ren, Chuan Xv, Dongqing Wang, et al.
Renal Failure|July 13, 2023
Effect of kidney disease on all-cause and cardiovascular mortality in patients undergoing coronary angiographyQiang Li, Shanshan Shi, Xiaozhao Lu, et al.
Journal of Cardiac Failure|September 5, 2020
Response to: Loutradis et al. Longer Dialysis Sessions Improve Cardiac Systolic Function by Reducing Myocardial StunningBrendan Smyth, Christopher T Chan, Stuart M Grieve, et al.
Journal of Cardiac Failure|April 18, 2020
Predictors of Change in Left-Ventricular Structure and Function in a Trial of Extended Hours HemodialysisBrendan Smyth, Christopher T Chan, Stuart M Grieve, et al.
Journal of Diabetes and Its Complications|January 10, 2019
Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney diseaseClement Lo, Edward Zimbudzi, Helena J Teede, et al.
Epilepsia|March 27, 2015
Does adherence to epilepsy quality measures correlate with reduced epilepsy-related adverse hospitalizations? A retrospective experienceTravis R Ladner, Clinton D Morgan, Daniel J Pomerantz, et al.
Pageof 19

Showing results (131-140 of 189) with videos related to

Sort By:
Pageof 19
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 5, 2014
The relationship between hypophosphataemia and outcomes during low-intensity and high-intensity continuous renal replacement therapyRinaldo Bellomo, Alan Cass, Louise Cole, et al.
Nephrology (Carlton, Vic.)|February 14, 2007
Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: a multicentre, open-label, Australian studyAlex Disney, Peter D E Jersey, Geoff Kirkland, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
The Plasma-Lyte 148 versus Saline (PLUS) statistical analysis plan: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortalityLaurent Billot, Rinaldo Bellomo, Martin Gallagher, et al.
Nephrology (Carlton, Vic.)|June 6, 2020
No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trialBrendan Smyth, Li Zuo, Nicholas A Gray, et al.
Frontiers in Immunology|June 3, 2024
The predictive value of systemic immune-inflammation index for vascular access survival in chronic hemodialysis patientsSong Ren, Chuan Xv, Dongqing Wang, et al.
Renal Failure|July 13, 2023
Effect of kidney disease on all-cause and cardiovascular mortality in patients undergoing coronary angiographyQiang Li, Shanshan Shi, Xiaozhao Lu, et al.
Journal of Cardiac Failure|September 5, 2020
Response to: Loutradis et al. Longer Dialysis Sessions Improve Cardiac Systolic Function by Reducing Myocardial StunningBrendan Smyth, Christopher T Chan, Stuart M Grieve, et al.
Journal of Cardiac Failure|April 18, 2020
Predictors of Change in Left-Ventricular Structure and Function in a Trial of Extended Hours HemodialysisBrendan Smyth, Christopher T Chan, Stuart M Grieve, et al.
Journal of Diabetes and Its Complications|January 10, 2019
Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney diseaseClement Lo, Edward Zimbudzi, Helena J Teede, et al.
Epilepsia|March 27, 2015
Does adherence to epilepsy quality measures correlate with reduced epilepsy-related adverse hospitalizations? A retrospective experienceTravis R Ladner, Clinton D Morgan, Daniel J Pomerantz, et al.
Pageof 19